Tina Ventura | SVP, IR |
Tim Walbert | Chairman, President and CEO |
Shao-Lee Lin | EVP, Head, R&D and Chief Scientific Officer |
Paul Hoelscher | EVP and CFO |
Vikram Karnani | EVP and Chief Commercial Officer |
Andy Pasternak | EVP Chief Business Officer |
David Amsellem | Piper Jaffray |
Annabel Samimy | Stifel |
Dana Flanders | Guggenheim |
Jason Gerberry | Bank of America |
Ken Cacciatore | Cowen |
Gary Nachman | BMO Capital Markets |
David Steinberg | Jefferies |
Good morning and thank you for standing by. Welcome to Horizon Therapeutics’ PLC Third Quarter 2019 Earnings Conference Call.
As a reminder, today’s conference is being recorded.
I would now like to introduce Ms. Tina Ventura, Senior Vice President of Investor Relations.